rs142426878
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001366110.1(PAX4):c.932C>T(p.Pro311Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000695 in 1,601,548 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001366110.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAX4 | NM_001366110.1 | c.932C>T | p.Pro311Leu | missense_variant | 12/12 | ENST00000639438.3 | NP_001353039.1 | |
PAX4 | NM_001366111.1 | c.914-203C>T | intron_variant | NP_001353040.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAX4 | ENST00000639438.3 | c.932C>T | p.Pro311Leu | missense_variant | 12/12 | 5 | NM_001366110.1 | ENSP00000491782.1 |
Frequencies
GnomAD3 genomes AF: 0.000466 AC: 71AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000282 AC: 64AN: 226900Hom.: 0 AF XY: 0.000286 AC XY: 35AN XY: 122508
GnomAD4 exome AF: 0.000719 AC: 1042AN: 1449350Hom.: 0 Cov.: 36 AF XY: 0.000702 AC XY: 505AN XY: 719714
GnomAD4 genome AF: 0.000466 AC: 71AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.000403 AC XY: 30AN XY: 74360
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 04, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant has not been reported in the literature in individuals affected with PAX4-related conditions. This variant is present in population databases (rs142426878, ExAC 0.06%). This sequence change replaces proline with leucine at codon 303 of the PAX4 protein (p.Pro303Leu). The proline residue is weakly conserved and there is a moderate physicochemical difference between proline and leucine. - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2019 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jul 03, 2018 | - - |
PAX4-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 23, 2024 | The PAX4 c.908C>T variant is predicted to result in the amino acid substitution p.Pro303Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.052% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Monogenic diabetes Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Personalized Diabetes Medicine Program, University of Maryland School of Medicine | Mar 01, 2016 | ACMG Criteria: PP3, BP4 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at